Global Drug Delivery Systems (DDS) Markets 2021-2027 - Increasing R&D Expenditures of Innovator Companies and the Trend of Patent Portfolio Expansion prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
About Arecor ( www.arecor.com )
Arecor Limited is a biopharmaceutical company transforming patient care by bringing innovative medicines to market. Through the enhancement of existing medicines using its Arestat™ technology, Arecor is developing a broad portfolio of therapies as part of its proprietary pipeline and through partnerships with leading pharmaceutical and biotech companies. Arecor s treatments for people living with chronic disease are designed to simplify patient care and improve medication adherence. For further details please visit www.arecor.com
About Inhibrx, Inc.
Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. Inhibrx has collaborations with bluebird bi